Follow this exact reviewed peptide identity across selected source lanes.
Official matched intervention · Drug
Copaxone®, clinical trials
2 selected ClinicalTrials.gov records carrying the official matched intervention Copaxone®, (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.
2 selected records.
1 profiles.
ClinicalTrials.gov intervention field.
Cross-source journeys
Explore connected peptide records
Across these connected profiles, PeptideScanner carries 25 selected PubMed records and 11 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.
Collection change ledger
Recently changed records on this intervention hub
These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.
ClinicalTrials.gov record NCT01216072
PeptideScanner retained ClinicalTrials.gov record NCT01216072 at 2026-11-16T17:42:50.457Z. Its registry update date was 2014-02-10, and PeptideScanner's reviewed identity mapping was glatiramer-acetate.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- February 10, 2014
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT01317004
PeptideScanner retained ClinicalTrials.gov record NCT01317004 at 2026-11-16T17:42:50.457Z. Its registry update date was 2015-06-22, and PeptideScanner's reviewed identity mapping was glatiramer-acetate.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- June 22, 2015
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Glatiramer acetate · 2015-06-22
ClinicalTrials.gov record NCT01317004
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2014-02-10
ClinicalTrials.gov record NCT01216072
Completed at the retained observation.
Open attributed record →